Intelligent Bio Solutions Inc. (INBS) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Intelligent Bio Solutions Inc. (INBS:NASDAQ), powered by AI.

Current Price
$3.14
P/E Ratio
-0.2
Market Cap
2M
Sector
Healthcare
What is the Intelligent Bio Solutions Inc. stock price forecast?

Intelligent Bio Solutions Inc. is currently trading at $3.14. View real-time AI analysis on Alpha Lenz.

What is Intelligent Bio Solutions Inc. insider trading activity?

View the latest insider trading data for Intelligent Bio Solutions Inc. on Alpha Lenz.

What is Intelligent Bio Solutions Inc.'s P/E ratio?

Intelligent Bio Solutions Inc.'s P/E ratio is -0.2.

Intelligent Bio Solutions Inc.

NASDAQ · INBS
$3.14+0.78(+33.05%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Intelligent Bio Solutions Inc.'s future dividend policy...
Alpha Chat Insight

Intelligent Bio Solutions Inc. trades at a P/E of -0.2 (undervalued) with modest ROE of -186.6%.

Ask for details

Company Overview

Intelligent Bio Solutions Inc. is a pioneering company in the biotechnology and medical technology sectors. The company's primary function is to advance health care solutions through the development of innovative, diagnostic technologies that focus on improving patient outcomes. It operates predominantly in the biosensor technology space, leveraging cutting-edge research and development to create highly sensitive diagnostic tools. Intelligent Bio Solutions Inc. plays a significant role in enhancing healthcare efficiency by offering rapid, accurate, and cost-effective diagnostic solutions. This is particularly impactful in areas such as disease management and healthcare delivery, where time-sensitive results are critical. The company collaborates across various healthcare institutions, contributing to sectors like clinical diagnostics, patient monitoring, and personalized medicine. By consistently driving technological advancements, Intelligent Bio Solutions Inc. helps to redefine standards in medical diagnostics, positioning itself as an integral player in transforming healthcare systems worldwide through innovative biosensor solutions.

CEOMr. Harry Simeonidis
SectorHealthcare
IndustryMedical Devices
Employees53

Company Statistics

FY 2025

Profile

$1.66MMarket Cap
$3.05MRevenue
0.00Shares Out
53Employees

Margins

40.85%Gross
-298.42%EBITDA
-341.50%Operating
-347.41%Pre-Tax
-347.41%Net

Valuation

-0.16P/E
0.55P/B
0.54EV/Sales
-0.08EV/EBITDA
-0.17P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-96.28%ROA
-186.64%ROE
-95.73%ROIC

Financial Health

$1.02MCash & Cash Equivalents
$4.42MNet Debt
193.19%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Intelligent Bio Solutions Inc. (ticker: INBS) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 53 employees. Market cap is $2M.

The current price is $3.14 with a P/E ratio of -0.16x and P/B of 0.55x.

ROE is -186.64% and operating margin is -341.50%. Annual revenue is $3M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Intelligent Bio Solutions Inc. (INBS) Stock Forecast 2026 $3.14 — Price, Financials & Analyst Targets | Alpha Lenz